Guohui Xu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma (NCT06485466) | Guohui Xu | 2024-08-10 |
Track Guohui Xu automatically
Every clearance here is in the API, with alerts when new ones post.